Latest news
Apogee Therapeutics (APGE) CMO trades stock under 10b5-1 plan - Stock TitanStock Titan · Sat, 08 Aug 2026 02:12:22 GMTApogee Therapeutics (NASDAQ:APGE) Insider Carl Dambkowski Sells 5,500 Shares - MarketBeatMarketBeat · Sat, 08 Aug 2026 01:40:52 GMTApogee Therapeutics CMO Carl Dambkowski disposes of USD 737,935 in common shares - BitgetBitget · Sat, 08 Aug 2026 00:43:41 GMTAPGE, Apogee Therapeutics, Inc., 2025-03-11, Stock Prices And MACD Indicators #MACD #APGE Al Nassr (6zlIIYGDqA) - MshaleMshale · Thu, 06 Aug 2026 14:30:59 GMTAbbVie Plans to raise $8 billion to finance deal with Apogee Therapeutics - AKM.RUAKM.RU · Wed, 05 Aug 2026 19:43:35 GMTAPGE, Apogee Therapeutics, Inc. Stock Prices Historical Data Kxan Weather (tghuNn6ymZ) - MshaleMshale · Wed, 05 Aug 2026 02:01:10 GMTAbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal - Bloomberg.comBloomberg.com · Tue, 04 Aug 2026 19:47:05 GMTApogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating the Biotech Landscape with a $10 Billion Market Cap - DirectorsTalk InterviewsDirectorsTalk Interviews · Tue, 04 Aug 2026 09:17:58 GMT